Stocks
Ionis Pharmaceuticals, Inc.IONS
NASDAQHealthcareBiotechnology$71.19-1.59%
A biotech firm specializing in RNA-targeted therapeutics, Ionis Pharmaceuticals develops treatments for rare and common diseases using antisense technology. The company has multiple FDA-approved drugs and a robust pipeline, making it a key player in genetic medicine. Investors monitor its clinical trial progress and partnerships with larger pharma companies.
Market Cap: $11.8B52W Range: $23.95 – $86.74
Congressional Interest in Ionis Pharmaceuticals, Inc. (IONS)
6 members of Congress have disclosed 12 trades in Ionis Pharmaceuticals, Inc. (IONS), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
6
Buys
8
Sells
4
Who in Congress Is Trading IONS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-13 | Rohit Khanna | buy | $1K – $15K |
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |